Forget Twitter – Telephone Script Also Snags FDA Citation
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of Prescription Drug Promotion objects to Concordia’s telephone script for attention deficit hyperactivity disorder drug Kapvay.